Assembly Biosciences said it has received a $20.1 million equity investment from Gilead Sciences, along with $10 million in accelerated funding. Gilead is buying the additional Assembly Bio stock, ...
Shares of Assembly Biosciences (NASDAQ:ASMB) traded higher on Thursday after Gilead Sciences (NASDAQ:GILD) agreed to increase ...
Assembly Bio to receive approximately $20.1 million equity investment and $10 million in accelerated funding under the collaboration, extending ...
Assembly Biosciences shares were up 19% at $16.01 after receiving an equity investment and accelerated funding from Gilead Sciences. Shares of the biotechnology company hit a 52-week high of $19.93 on ...
Assembly Biosciences (ASMB) announced an equity investment of $20.1M by Gilead Sciences (GILD) to purchase additional Assembly Bio common stock and an amendment to their collaboration to advance the ...
Dec. 19, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced ...
Assembly Biosciences said it has received a $20.1 million equity investment from Gilead Sciences, along with $10 million in accelerated funding. Gilead is buying the additional Assembly Bio stock ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback